Illingworth Research Group

This is is part of my live-learning series! I will be updating this post as I continue through my journey. I apologize for any grammatical errors or incoherent thoughts. This is a practice to help me share things that are valuable without falling apart from the pressure of perfection. 

“About Illingworth

Who we are, what we do,

our mascot and more…

Our vision… To be the best Mobile Research Nursing provider in the world

Illingworth Research Group’s primary drive is to become the best Mobile Research Nursing provider in the world. Offering the service globally and to the highest of standards to deliver a service which truly adds value to both patients and sponsors.

Illingworth strives to achieve this whilst still maintaining core beliefs… passion for research, compassion for patients. We aim to achieve global preferred provider/partner status to continue the growth of our patient centric services, thus broadening their reach and continuing to empower patients and make clinical trial participation easier and more effective for both patients and sponsors.

About Illingworth

Focused on pioneering the patient experience

Illingworth Research Group provides a range of clinical development services to the pharmaceutical, healthcare, biotechnology and medical device industries. We are experts in providing Research Nursing for Phase I to IV clinical trials across many different therapeutic areas. We have grown organically over our 20 year history offering all services near globally. On and Off-Site Research Nursing capabilities continue to expand in support of the patient centricity movement.

Illingworth Research has an exceptionally dedicated team, the company is structured to deliver a bespoke service to a sponsor’s requirements: strategic insight, high calibre people, flexibility, quality, and highly motivated, high performing teams. Our focus on attracting, training, resourcing and retaining the best talent in the industry, has proved a key strategic investment and lead clients to repeatedly asking for particular staff to work on their projects again. Our team aim to offer open, honest channels of communication and a flexible supportive approach, in a service designed for you.

Management Team

Management team

Meet the Illingworth Research Group management team! Our team has over 100 years’ experience in clinical trials across many disciplines including nursing, mobile nursing, clinical photography and much more.

John Illingworth Chairman

Having gained over 30 years of experience, initially at ICI (now AstraZeneca) and Serono. He founded the company in 1998. John spent 10 years teaching on the MSc in Clinical Research courses at Liverpool John Moores University and is still an honorary lecturer. He was on the executive committee of the Institute for Clinical Research in the pharmaceutical industry for 6 years. Whilst gaining his Institute of Directors Diploma in company direction, John continued to oversee the steady expansion of the company, promoting within the UK and overseas to the biotech, pharmaceutical and medical device industries and is a familiar and respected face at conferences, exhibitions and seminars all over the world.

Helen Springford Chief Executive Officer

Helen has been with Illingworth for 4 years, initially as Vice President, Strategic Development and then Chief Operating Officer. Helen has been pivotal in bringing process improvements and has developed a superb Business Development function to drive the company. Helen is a seasoned professional with 30 years industry experience. Helen graduated with an honours degree in Nursing Sciences and started her clinical trials career as a research nurse in London. Helen has managed an SMO and held various positions in CROs and big pharma within several functional areas including Clinical Operations, Project Management and Business Development. Her combination of nursing background, clinical and business skills will ensure Illingworth realise their goals over the coming years.

Dr Mike Davies Chief Medical Officer

A high achieving Medic and Surgeon and latterly senior pharmaceutical executive. His significant history in both medicine and surgery facilitated his transition into pharmaceutical medicine, where he developed over ten patents for work in the discovery of wound healing, dermatology and cardiovascular compounds. Mike has provided scientific and medical expertise and leadership to a global product strategy from concept through to registration and throughout the life-cycle of important and valuable medical compounds.

Having completed clinical research in all four phases of drug development and gained extensive experience in areas of drug development and marketing, Mike now provides consultancy advice on pharmaceutical and clinical affairs.

Juliet “Jules” Moritz Chief Operating Officer

Jules is a highly experienced pharmaceutical professional with over 30 years of clinical research experience. Jules completed her undergraduate work in biology and nursing at the University of Pennsylvania. She earned her Master of Public Health degree with honors from the Drexel University Dornsife School of Public Health.

She has worked for both sponsor companies and for CROs across a number of therapeutic areas, overseeing trials that range from a 10,000 patient cardiovascular program to a four patient ultra-rare gene therapy trial. She has worked for both sponsor companies and for CROs across a number of therapeutic areas, overseeing trials that range from a 10,000 patient cardiovascular program to a four patient ultra-rare gene therapy trial.

Gerard Baron Vice President of Operations

Gerard joined Illingworth Research in June 2019 as Director of Clinical Operations. Gerard has extensive experience leading and working with talented individuals and has successfully delivered many clinical projects from inception to completion across all phases and in various neurological, oncology inflammatory, autoimmune and rare disease indications over the 20 + years he has been in the pharmaceutical industry. Gerard has a keen interest in innovation in clinical trials and has spoken on patient centricity, risk-based monitoring and implementation of technology in clinical trials as well as the need for sponsors to demonstrate the oversight of their vendors in compliance with ICH GCP updates.

Juliet Hulse Senior Director, Global RN Strategy and Patient Advocacy

Juliet joined the company in 2011 as a Senior Research Nurse and after several promotions was appointed to her current the position in 2020 . Juliet has over 20 years’ experience within clinical research, commencing her career in cardiology research covering multiple Phase I- IV trials. Juliet more recently specialised in neurology research, in particular, the field of multiple sclerosis. She has wide experience in the management of trial projects from initiation to close out as well as working with site investigators to improve patient recruitment and patient retention to the study protocols. She believes developing a strategy that places the patient in the centre of the trial is vital for a successful study.

Illingworth Bear


50+ Countries traveled…so far!

3500+ Families reached… en-counting

60+ Conferences attended”

Learn more at

More To Explore

Share This Post

Join My Personal Newsletter ❤

Get insights and resources into awareness, well-being, productivity, technology, psychedelics and more.

Don't want to chat but want to keep updated?

I'd love if you subscribed today. I promise I will only send you great, valuable content that has transformed me and helped others flourish. 

You have Successfully Subscribed!

Pin It on Pinterest